vancomycin hydrochloride
Phase 3Small molecule
vancomycin hydrochloride is one of 9 small molecule programs targeting Dental Caries. It is currently in Phase 3.
2
Indications
5
Total Trials
2
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
7 competitors in Dental Caries
#DrugCompanyPhaseTrials
1Peridex
DDexcel Pharma Technologies Ltd.
Approved
Betadine
BBecton, Dickinson and Company
Approved
Mycostatin
GGood Molecules, LLC
Approved
Zocor
OOrganon and Co
Approved
vancomycin hydrochloride
WWake Forest University Health Sciences
Phase 3
KH001
HHysensBio Co., Ltd
Phase 2
Chlorhexidine Digluconate
GSKPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Dental Caries1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for vancomycin hydrochloride. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details